IMC Chicago’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-10,200
Closed -$1.81M 986
2020
Q1
$1.81M Sell
10,200
-44,800
-81% -$8.44M ﹤0.01% 515
2019
Q4
$10.5M Sell
55,000
-2,900
-5% -$523K 0.03% 208
2019
Q3
$9.74M Sell
57,900
-54,500
-48% -$8.88M 0.03% 184
2019
Q2
$18.8M Buy
112,400
+85,300
+315% +$11.8M 0.06% 107
2019
Q1
$3.97M Sell
27,100
-8,400
-24% -$1.22M 0.01% 268
2018
Q4
$4.75M Buy
+35,500
New +$5.82M 0.01% 212

Other funds holding AGN

IMC Chicago's AGN Position: Q2 2020 in Review

IMC Chicago sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 55,238 shares — an estimated $9.78M sold.

IMC Chicago first reported a position in AGN in Q1 2020 and held it in 1 quarter. The position peaked at $9.78M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • IMC Chicago reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • IMC Chicago sold 55,238 Allergan plc shares in Q2 2020, an estimated $9.78M.
  • IMC Chicago first reported a position in Allergan plc in Q1 2020 and held it in 1 quarter.
  • IMC Chicago's Allergan plc position peaked at $9.78M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on IMC Chicago's 13F filing for Q2 2020, filed 14 Aug 2020.